Clinical Trial Update: Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating consolidation therapy with fulvestrant and anastrozole in postmenopausal women with advanced non-small cell lung cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)

Snippet

Sponsor: University of Pittsburgh | Conditions: Non-small Cell Lung Cancer, Postmenopausal Women | Phase 2 | Status: TERMINATED | Results posted: 2016-08-31